Christopher F. Claiborne

Person

Lansdale, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Aurora kinase inhibitors for inhibiting mitotic progression
- Patent number 9,988,384
- Issue date Jun 5, 2018
- Millennium Pharmaceuticals, Inc.
- Christopher F. Claiborne
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and methods for inhibiting mitotic progression
- Patent number 9,765,078
- Issue date Sep 19, 2017
- Millennium Pharmaceuticals, Inc.
- Christopher F. Claiborne
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aurora kinase inhibitors for inhibiting mitotic progression
- Patent number 9,765,076
- Issue date Sep 19, 2017
- Millenium Pharmaceuticals, Inc.
- Christopher F. Claiborne
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl compounds useful as inhibitors of E1 activating enzymes
- Patent number 9,718,788
- Issue date Aug 1, 2017
- Millennium Pharmaceuticals, Inc.
- Christopher F. Claiborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaryl compounds useful as inhibitors of E1 activating enzymes
- Patent number 9,458,108
- Issue date Oct 4, 2016
- Millennium Pharmaceuticals, Inc.
- Christopher F. Claiborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaryl compounds useful as inhibitors of E1 activating enzymes
- Patent number 9,150,525
- Issue date Oct 6, 2015
- Millennium Pharmaceuticals, Inc.
- Christopher F. Claiborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and methods for inhibiting mitotic progression
- Patent number 9,102,678
- Issue date Aug 11, 2015
- Millennium Pharmaceuticals, Inc.
- Christopher F. Claiborne
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl compounds useful as inhibitors of E1 activating enzymes
- Patent number 8,481,550
- Issue date Jul 9, 2013
- Millennium Pharmaceuticals, Inc.
- Christopher F. Claiborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoquinolinone potassium channel inhibitors
- Patent number 8,338,449
- Issue date Dec 25, 2012
- Merck Sharp & Dohme Corp.
- B. Wesley Trotter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aurora kinase inhibitors for inhibiting mitotic progression
- Patent number 8,026,246
- Issue date Sep 27, 2011
- Millennium Pharmaceuticials, Inc.
- Christopher F. Claiborne
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl compounds useful as inhibitors of E1 activating enzymes
- Patent number 8,008,307
- Issue date Aug 30, 2011
- Millennium Pharmaceuticals, Inc.
- Christopher F. Claiborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Lactam compounds useful as protein kinase inhibitors
- Patent number 7,935,694
- Issue date May 3, 2011
- Millennium Pharmaceuticals, Inc.
- Christopher Blackburn
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoquinolinone potassium channel inhibitors
- Patent number 7,723,352
- Issue date May 25, 2010
- Merck Sharp & Dohme
- B. Wesley Trotter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyridobenzazepine compounds and methods for inhibiting mitotic prog...
- Patent number 7,718,648
- Issue date May 18, 2010
- Millennium Pharmaceuticals, Inc.
- Christopher F. Claiborne
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-fluoro-piperidines as NMDA/NR2B antagonists
- Patent number 7,592,360
- Issue date Sep 22, 2009
- Merck & Co., Inc.
- Nigel J. Liverton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and methods for inhibiting mitotic progression
- Patent number 7,572,784
- Issue date Aug 11, 2009
- Millennium Pharmaceuticals, Inc.
- Christopher F. Claiborne
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Lactam compounds useful as protein kinase inhibitors
- Patent number 7,459,448
- Issue date Dec 2, 2008
- Millennium Pharmaceuticals, Inc.
- Christopher Blackburn
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Melanocortin-4 receptor binding compounds and methods of use thereof
- Patent number 7,375,125
- Issue date May 20, 2008
- Ore Pharmaceuticals, Inc.
- Tricia J. Vos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists
- Patent number 7,259,157
- Issue date Aug 21, 2007
- Merck & Co., Inc.
- Nigel J. Liverton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists
- Patent number 7,217,716
- Issue date May 15, 2007
- Merck & Co., Inc.
- Christopher F. Claiborne
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists
- Patent number 7,053,089
- Issue date May 30, 2006
- Merck & Co., Inc.
- Christopher F. Claiborne
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted imidazoles having cytokine inhibitory activity
- Patent number 6,767,908
- Issue date Jul 27, 2004
- Merck & Co., Inc.
- Christopher F. Claiborne
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Carbocyclic potassium channel inhibitors
- Patent number 6,632,836
- Issue date Oct 14, 2003
- Merck & Co., Inc.
- Robert K. Baker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclic amidines useful as NMDA NR2B antagonists
- Patent number 6,376,530
- Issue date Apr 23, 2002
- Merck & Co., Inc.
- Christopher F. Claiborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aryl amidines, compositions containing such compounds and methods o...
- Patent number 6,319,944
- Issue date Nov 20, 2001
- Merck & Co., Inc.
- Christopher F. Claiborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists
- Patent number 6,316,474
- Issue date Nov 13, 2001
- Merck & Co., Inc.
- John A. McCauley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic potassium channel inhibitors
- Patent number 6,303,637
- Issue date Oct 16, 2001
- Merck & Co., Inc.
- Jianming Bao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds having cytokine inhibitory activity
- Patent number 6,291,457
- Issue date Sep 18, 2001
- Merck & Co., Inc.
- Christopher F. Claiborne
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted imidazoles having cytokine inhibitory activity
- Patent number 6,207,687
- Issue date Mar 27, 2001
- Merck & Co., Inc.
- Christopher F. Claiborne
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzamide potassium channel inhibitors
- Patent number 6,194,458
- Issue date Feb 27, 2001
- Merck & Co., Inc.
- Robert K. Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF E1 ACTIVATING ENZYMES
- Publication number 20170050935
- Publication date Feb 23, 2017
- Millennium Pharmaceuticals, Inc.
- Christopher F. CLAIBORNE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND METHODS FOR INHIBITING MITOTIC PROGRESSION
- Publication number 20160185782
- Publication date Jun 30, 2016
- Millennium Pharmaceuticals, Inc.
- Christopher F. Claiborne
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF E1 ACTIVATING ENZYMES
- Publication number 20160039761
- Publication date Feb 11, 2016
- Millennium Pharmaceuticals, Inc.
- Christopher F. CLAIBORNE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF E1 ACTIVATING ENZYMES
- Publication number 20150183753
- Publication date Jul 2, 2015
- Millennium Pharmaceuticals, Inc.
- Christopher F. Claiborne
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Aurora Kinase Inhibitors for Inhibiting Mitotic Progression
- Publication number 20150166545
- Publication date Jun 18, 2015
- Millennium Pharmaceuticals, Inc.
- Christopher F. Claiborne
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF E1 ACTIVATING ENZYMES
- Publication number 20140303193
- Publication date Oct 9, 2014
- Millennium Pharmaceuticals, Inc.
- Christopher F. Claiborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND METHODS FOR INHIBITING MITOTIC PROGRESSION
- Publication number 20140046055
- Publication date Feb 13, 2014
- Millennium Pharmaceuticals, Inc.
- Christopher F. Claiborne
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF E1 ACTIVATING ENZYMES
- Publication number 20130345242
- Publication date Dec 26, 2013
- Millennium Pharmaceuticals, Inc.
- Christopher F. Claiborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LACTAM COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS
- Publication number 20120178739
- Publication date Jul 12, 2012
- Millennium Pharmaceuticals, Inc.
- Christopher Blackburn
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF E1 ACTIVATING ENZYMES
- Publication number 20120071482
- Publication date Mar 22, 2012
- Millennium Pharmaceuticals, Inc.
- Christopher F. Claiborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AURORA KINASE INHIBITORS FOR INHIBITING MITOTIC PROGRESSION
- Publication number 20110312942
- Publication date Dec 22, 2011
- Millennium Pharmaceuticals, Inc.
- Christopher F. Claiborne
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AURORA KINASE INHIBITORS FOR INHIBITING MITOTIC PROGRESSION
- Publication number 20110312943
- Publication date Dec 22, 2011
- Millennium Pharmaceuticals, Inc.
- Christopher F. Claiborne
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LACTAM COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS
- Publication number 20110039820
- Publication date Feb 17, 2011
- Millennium Pharmaceuticals, Inc.
- Christopher Blackburn
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Isoquinolinone Potassium Channel Inhibitors
- Publication number 20100256698
- Publication date Oct 7, 2010
- Merck & Co., Inc.
- B. Wesley Trotter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND METHODS FOR INHIBITING MITOTIC PROGRESSION
- Publication number 20090299060
- Publication date Dec 3, 2009
- Millennium Pharmaceuticals, Inc.
- Christopher F. Claiborne
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Lactam compounds useful as protein kinase inhibitors
- Publication number 20090105213
- Publication date Apr 23, 2009
- Millennium Pharmaceuticals, Inc.
- Christopher Blackburn
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Melanocortin-4 receptor binding compounds and methods of use thereof
- Publication number 20080269217
- Publication date Oct 30, 2008
- Ore Pharmaceuticals, Inc.
- Tricia J. Vos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds for inhibiting mitotic progression
- Publication number 20080167292
- Publication date Jul 10, 2008
- Millennium Pharmaceuticals, Inc.
- Christopher F. Claiborne
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heteroaryl compounds useful as inhibitors of E1 activating enzymes
- Publication number 20080051404
- Publication date Feb 28, 2008
- Millennium Pharmaceuticals, Inc.
- Christopher F. Claiborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pyridobenzazepine compounds and methods for inhibiting mitotic prog...
- Publication number 20080045501
- Publication date Feb 21, 2008
- Millennium Pharmaceuticals, Inc.
- Christopher F. Claiborne
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
- Publication number 20070149568
- Publication date Jun 28, 2007
- Nigel J Liverton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Isoquinolinone potassium channel inhibitors
- Publication number 20070027177
- Publication date Feb 1, 2007
- B. Wesley Trotter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Lactam compounds useful as protein kinase inhibitors
- Publication number 20060100194
- Publication date May 11, 2006
- Millennium Pharmaceuticals, Inc.
- Christopher Blackburn
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds and methods for inhibiting mitotic progression
- Publication number 20050256102
- Publication date Nov 17, 2005
- Millennium Pharmaceuticals, Inc.
- Christopher F. Claiborne
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
- Publication number 20040209889
- Publication date Oct 21, 2004
- Christopher F. Claiborne
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Melanocortin-4 receptor binding compounds and methods of use thereof
- Publication number 20040082779
- Publication date Apr 29, 2004
- Millennium Pharmaceuticals, Inc.
- Tricia J. Vos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists
- Publication number 20030119811
- Publication date Jun 26, 2003
- Nigel J. Liverton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists
- Publication number 20020165241
- Publication date Nov 7, 2002
- Christopher F. Claiborne
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted imidazoles having cytokine inhibitory activity
- Publication number 20020026056
- Publication date Feb 28, 2002
- Christopher F. Claiborne
- C07 - ORGANIC CHEMISTRY

Christopher F. Claiborne

Person

Patents Grantslast 30 patents

Aurora kinase inhibitors for inhibiting mitotic progression

Compounds and methods for inhibiting mitotic progression

Aurora kinase inhibitors for inhibiting mitotic progression

Heteroaryl compounds useful as inhibitors of E1 activating enzymes

Heteroaryl compounds useful as inhibitors of E1 activating enzymes

Heteroaryl compounds useful as inhibitors of E1 activating enzymes

Compounds and methods for inhibiting mitotic progression

Heteroaryl compounds useful as inhibitors of E1 activating enzymes

Isoquinolinone potassium channel inhibitors

Aurora kinase inhibitors for inhibiting mitotic progression

Heteroaryl compounds useful as inhibitors of E1 activating enzymes

Lactam compounds useful as protein kinase inhibitors

Isoquinolinone potassium channel inhibitors

Pyridobenzazepine compounds and methods for inhibiting mitotic prog...

3-fluoro-piperidines as NMDA/NR2B antagonists

Compounds and methods for inhibiting mitotic progression

Lactam compounds useful as protein kinase inhibitors

Melanocortin-4 receptor binding compounds and methods of use thereof

N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists

N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists

N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists

Substituted imidazoles having cytokine inhibitory activity

Carbocyclic potassium channel inhibitors

Cyclic amidines useful as NMDA NR2B antagonists

Aryl amidines, compositions containing such compounds and methods o...

2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists

Heterocyclic potassium channel inhibitors

Compounds having cytokine inhibitory activity

Substituted imidazoles having cytokine inhibitory activity

Benzamide potassium channel inhibitors

Patents Applicationslast 30 patents

HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF E1 ACTIVATING ENZYMES

COMPOUNDS AND METHODS FOR INHIBITING MITOTIC PROGRESSION

HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF E1 ACTIVATING ENZYMES

HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF E1 ACTIVATING ENZYMES

Aurora Kinase Inhibitors for Inhibiting Mitotic Progression

HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF E1 ACTIVATING ENZYMES

COMPOUNDS AND METHODS FOR INHIBITING MITOTIC PROGRESSION

HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF E1 ACTIVATING ENZYMES

LACTAM COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS

HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF E1 ACTIVATING ENZYMES

AURORA KINASE INHIBITORS FOR INHIBITING MITOTIC PROGRESSION

AURORA KINASE INHIBITORS FOR INHIBITING MITOTIC PROGRESSION

LACTAM COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS

Isoquinolinone Potassium Channel Inhibitors

COMPOUNDS AND METHODS FOR INHIBITING MITOTIC PROGRESSION

Lactam compounds useful as protein kinase inhibitors

Melanocortin-4 receptor binding compounds and methods of use thereof

Compounds for inhibiting mitotic progression

Heteroaryl compounds useful as inhibitors of E1 activating enzymes

Pyridobenzazepine compounds and methods for inhibiting mitotic prog...

N-substituted nonaryl-heterocyclic nmda/nr2b antagonists

Isoquinolinone potassium channel inhibitors

Lactam compounds useful as protein kinase inhibitors

Compounds and methods for inhibiting mitotic progression

N-substituted nonaryl-heterocyclic nmda/nr2b antagonists

Melanocortin-4 receptor binding compounds and methods of use thereof

N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists

N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists

Substituted imidazoles having cytokine inhibitory activity